At what enterprise value was INTECH MEDICAL acquired in 2021?

During the acquisition of INTECH MEDICAL by MONTAGU PRIVATE EQUITY in 2021, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of INTECH MEDICAL when it was acquired by MONTAGU PRIVATE EQUITY?

The estimated EV/EBITDA multiple for INTECH MEDICAL is in the range of 15x - 25x.

When was INTECH MEDICAL acquired by MONTAGU PRIVATE EQUITY?

INTECH MEDICAL was acquired by MONTAGU PRIVATE EQUITY in 2021.

What was the revenue of INTECH MEDICAL at the time of the deal?

The revenue of INTECH MEDICAL at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of INTECH MEDICAL during the acquisition?

INTECH MEDICAL's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the INTECH MEDICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the INTECH MEDICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.agefi.fr/private-equity/actualites/eurazeo-revend-intech-medical-plus-de-500-millions-deuros

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaINTECH MEDICAL

07/2021

INTECH MEDICAL acquired by MONTAGU PRIVATE EQUITY

FRANCE Life Sciences / Medical Devices / Implants & Prosthetics EV 500M - 1.5b EUR

Context

Intech Medical, a global leader in the manufacturing of orthopedic surgical instruments and implants, has entered into an agreement to be acquired by Montagu Private Equity. The transaction marks the exit of Eurazeo (specifically its mid-cap subsidiary) and Andera Partners, who have held a majority stake in the French group since 2017.

INTECH MEDICAL, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Intech (In'Tech Medical) is a premier global contract design and manufacturing organization (CDMO) specialized in the orthopedic medical device industry. Founded in 1999 and headquartered in Rang-du-Fliers, France, the company serves as a mission-critical partner for major medical technology OEMs across the Spine, Trauma, Knee, Hip, and Sports Medicine sectors. Powered by over 1,200 employees across 9 state-of-the-art facilities in Europe, the US, and Asia, Intech’s extensive capabilities span from prototype design to large-scale manufacturing of complex surgical instruments, cutting tools, implants, silicone handles, and sterilization trays, alongside its smart asset-tracking IoMT division, SMADE.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2021	COLOPLAST	ATOS MEDICAL	SWEDEN	Medical Consumables
09/2021	PERRIGO COMPANY	HRA PHARMA	FRANCE	Generics / Labs
07/2021	ORKLA	NUTRAQ	Norway	Nutrition & Dietary Supplements
07/2021	PARTNERS GROUP	PHARMATHEN	GREECE	CDMO
04/2021	NAXICAP PARTNERS	LAGARRIGUE	FRANCE	Implants & Prosthetics
04/2021	DIASORIN	LUMINEX CORPORATION	UNITED STATES	Diagnostic Equipment
03/2021	CVC	COOPER-VEMEDIA	FRANCE	Generics / Labs
02/2021	SIPAREX	WINNCARE	FRANCE	Medical Devices
02/2021	IK PARTNERS	Innovad Group	BELGIUM	Animal Health
01/2021	ARDIAN / BNP PARIBAS DEVELOPPEMENT	PROTEOR	FRANCE	Implants & Prosthetics

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 100M - 200M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INTECH MEDICAL by MONTAGU PRIVATE EQUITY are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: intech medical

Acquirer: montagu private equity